James A. Smith, III, MD

James A. Smith, III, MD

PHEN Ambassador, Virginia

Dr. James A. Smith, III is a retired psychiatrist with 46 years of service to the community. He is also a PHEN Ambassador and the immediate past President of the North Carolina Minority Prostate Cancer Awareness Action Team. He has worked as both a health educator and a psychiatrist for over 40 years. Dr. Smith was the Medical Director Emeritus of Mind Path Health, LLC, which was the largest psychiatric practice in the nation at the time of his retirement.

He completed his education at Howard University in Washington, DC, where he obtained his BS and M.D.  He completed his internship in Internal Medicine at Harlem Hospital and his residency in Psychiatry at Walter Reed Army Medical Center. He left the Army after Desert Storm/Shield with the rank of Lieutenant Colonel. He is board-certified in Psychiatry by the American Board of Psychiatry and Neurology. He is proud to be a second-generation psychiatrist, following in his father’s footsteps in this profession. His father is also a Howard University medical graduate. He has held faculty appointments with both Duke University and the UNC Departments of Psychiatry. He was Chair of the Wake County Human Services Board from 2014 to 2019. Then he was selected as the Chair of the Board of Directors of Urban Ministries of Wake Co. until May of 2023. He has been a Board Member of the Governor’s Institute on Alcoholism and Substance Abuse and Catholic Social Ministries, Diocese of Raleigh. Most recently, he was selected by the Loudoun County Board of Supervisors to be on the Health System Advisory Board of Northern Virginia, and on June 15th, he was selected to be a board member of Shelter House of Fairfax and Loudoun Counties, addressing homelessness and domestic violence.

He is a member of the North Carolina Psychiatric Association and the American Psychiatric Association, where he is a Distinguished Life Fellow. He has been a member of the Advisory Council of the Rex Prostate Cancer Center of Excellence, and he remains on the Community Advisory Board of the UNC Lineberger Cancer Center.

Dr. Smith was honored by North Carolina Governor Roy Cooper for his commitment to the health and well-being of the citizens of Eastern North Carolina, as he bestowed on Dr. Smith the “Order of the Long Leaf Pine Award”. Maryland Governor Wes Moore also awarded him a Governor’s Citation at the annual Emanual Health Education Center awards ceremony on prostate cancer in September of 2024, where he was awarded their “Lifetime Achievement Award”. Dr. Smith and his sister, Mrs. Melanie Felton, are establishing an endowment at Howard University to give yearly the “Smith Family Award” to a graduating medical student going into psychiatry to honor his father and a second award to a graduating medical student going into infectious disease to honor their sister, Dr. Margo Ann Smith.

Diah Douglas, MD

Diah Douglas, MD

Diah Douglas, MD

Diah Douglas, MD

Senior Medical Director, Oncology, Lantheus

Diah Douglas, MD, is a Senior Medical Director, Oncology, within Global Medical Affairs at Lantheus. She brings extensive experience across medical affairs, clinical medicine, and healthcare consulting, with a strong focus on evidence generation, medical strategy, and cross‑functional collaboration in oncology.

In her current role, Dr. Douglas provides medical affairs leadership for an oncology portfolio that includes prostate cancer. She serves as a core medical lead, contributing to strategic planning, launch readiness, investigator‑sponsored research oversight, and medical governance, while partnering closely with internal and external stakeholders.

Prior to joining Lantheus, Dr. Douglas served as a Medical Director in Oncology within U.S. Medical Affairs at a global biopharmaceutical company, where she helped shape medical strategy across oncology programs spanning small molecules and immuno‑oncology. Her experience includes launch planning, strategic medical initiatives, health economics research, and key opinion leader engagement across multiple stages of development.

Dr. Douglas has a strong foundation in clinical medicine, having trained in general surgery after earning her MD from NYU School of Medicine. Before transitioning into industry, she spent nearly a decade in healthcare management consulting, advising biotechnology and pharmaceutical companies on clinical development and commercial strategy across multiple therapeutic areas.

She received her undergraduate degrees from Brown University, where she studied Psychology and East Asian Studies.

Go to the 22nd Annual Summit Session:

Mr. Jerry Womack

Mr. Jerry Womack

Prostate Cancer Survivor and PHEN Ambassador

Prostate Cancer Survivor and PHEN Ambassador

Mr. Jerry Womack is a U.S. Air Force Veteran and a retired Sales & Building Environmental Services Executive. He is a long-term PHEN advocate and one of the original PHEN Survivor Network Members. He served as the leader of the “Man to Man” support group component of PHEN’s monthly Managing Survivorship Meetings. After relocating to Charlotte, North Carolina in 2015, Mr. Womack became PHEN Ambassador for the Charlotte, NC area. 

He is a prostate cancer survivor and ambassador for the Prostate Health Education Network. As a prostate cancer survivor, he was diagnosed in the early stages due to early detection methods. He underwent multiple treatment options and was able to receive treatment while the cancer was in a low-grade status and believed to be contained. With a blessing from God for extended life, he has been on a mission to share with everyone who will listen about the importance of managing prostate health through early detection and frequent follow-up visits.

Go to the 22nd Annual Summit Session:

Dr. Adam B. Murphy

Dr. Adam B. Murphy

Associate Professor, Feinberg School of Medicine

Associate Professor, Feinberg School of Medicine

Northwestern Medical Group

Clinically, I am interested in general urology, men’s health, and the management of elevated PSA. For my research, I have been studying the variation in biomarker accuracy across populations in prostate cancer to improve precision medicine. We have been looking at the role of biomarkers and risk prediction tools to improve outcomes for men at risk of prostate cancer or diagnosed with prostate cancer. I am also interested in improving the safety and compliance in active surveillance for prostate cancer in safety net and community settings.

Dr. Keith Crawford

Dr. Keith Crawford

Director of Clinical Trials and Patient Education

Director of Clinical Trials and Patient Education

PHEN

Dr. Keith Crawford joined PHEN in 2019.  As Director of Clinical Trials and Patient Education, he is responsible for implementing programs in these areas as well as working with patients and PHEN partners.

Dr. Crawford has more than 20 years of experience in the Life Sciences and completed his graduate and post-graduate training at Harvard Medical School where he developed competencies in the area of genomics, proteomics, immunology, microbiology, infectious diseases, and regenerative medicine.

During his post-doctoral training, Keith was selected by the Robert Wood Johnson Foundation as a Harold Amos Fellow. His work in the field of immunology caught the eye of the Department of Defense where he received funding to develop antidotes for chemical and biological weapons exposure as well as create a high throughput platform for the detection of biological weapons and emerging infectious agents.

After completing this directive, Dr. Crawford became the Director of the Center for Molecular Orthopedics at Brigham and Women’s Hospital. He was responsible for leading research efforts at the center, which gave rise to the discovery of a novel population of early lineage adult stem cells.  Dr. Crawford and his colleagues were responsible for the preclinical studies, which laid the foundation for a spinal fusion therapeutic. 

Dr. Crawford is a graduate of Prairie View University, the University of Texas Medical School in Houston (Medical Doctorate), and Harvard University (Doctor Philosophy) where he studied cell biology and immunology.

Mr. Thomas A. Farrington

Mr. Thomas A. Farrington

President and Founder

President and Founder

PHEN

Thomas Farrington founded the Prostate Health Education Network (PHEN) in 2003 after receiving treatment for prostate cancer in 2000 and publishing his first book Battling The Killer Within in 2001. Under Mr. Farrington’s leadership, PHEN is recognized as the leading prostate cancer education and advocacy organization with national programs and initiatives focused on the needs of African Americans.

A key foundation for PHEN’s success is its national network of prostate cancer survivors and their loved ones who support the organization’s efforts within their communities. PHEN partners with hundreds of churches across the nation to bring education and awareness programs into their communities and recruit local prostate cancer medical specialists as educators for these events.

PHEN also makes extensive use of online programming to reach and support individual educational needs. Mr. Farrington’s background is in Information Technology.  Farrington currently serves as a member of the National Comprehensive Cancer Network’s (NCCN) Prostate Cancer Treatment Guidelines Panel and the NCCN Prostate Cancer Early Detection Guidelines Panel. He serves as a trustee of the Dana-Farber Cancer Institute and as an advisor to a number of other healthcare organizations and programs. Mr. Farrington received a B.S. in Electrical Engineering from North Carolina Agricultural and Technical State University in 1966.

Go to the 22nd Annual Summit Session: